Skip to main content

TPRM Consulting

Home / Industries / Healthcare

Third-Party Risk Management for Healthcare and Life Sciences

Care now depends on suppliers for clinical systems, devices, diagnostics and data. Regulators increasingly expect providers and manufacturers to show that those dependencies are understood, tested and under control.

Our approach

The discipline of regulated finance, applied to care

We bring the third-party risk practice built in heavily supervised financial services: evidence over attestation, criticality judged by consequence, and remediation followed through to closure.

What's changing

Five shifts in healthcare third-party risk

Clinical safety becomes part of supplier assurance

A safe product doesn’t guarantee a safe deployment. Assurance has to follow the manufacturer’s safety evidence into local configuration, integration and workflow.

Rules: DCB0129 and DCB0160 (England), DTAC.

How we help: Assess, with testing that follows the evidence into deployment.

Critical suppliers come into scope

The supplier that matters most isn’t always the biggest contract. It’s the one whose failure would stop a clinical service and couldn’t be replaced quickly, as the 2024 attack on a London pathology provider showed.

Rules: the NIS Regulations, NIS2 in the EU, and the proposed Cyber Security and Resilience Bill.

How we help: Define for tiering by consequence, Oversee for concentration risk.

Medical devices outlive their software

A device can stay in clinical use long after a component, cloud service or support route behind it has reached end of life.

Rules: UK and EU post-market surveillance, EU MDR cybersecurity guidance.

How we help: Oversee, with end-of-support triggers and exit readiness. Read the article →

AI assurance continues after go-live

An AI tool approved at procurement may not be the same tool a year later. Changes to the model, data or workflow need to be tracked and reassessed.

Rules: the EU AI Act, and the UK government’s response to the commission on AI in healthcare.

How we help: AI supplier assessment, led by a BSI-certified ISO/IEC 42001 Lead Auditor.

Health data has to move safely between suppliers

Owning your data isn’t the same as being able to move it, complete and with its clinical meaning intact, when you change supplier.

Rules: the European Health Data Space, UK GDPR.

How we help: Define, with contract, exit and data-portability standards.

Rules that apply

The frameworks we map to

UK GDPR for patient data.

The NHS Data Security and Protection Toolkit (DSPT).

DTAC for digital health suppliers.

DCB0129 and DCB0160 clinical safety standards in England.

The NIS Regulations.

Medical device rules: the MHRA’s UK regime and the EU MDR.

ISO 27001 and SOC 2 reports, relied on where they cover the service.

What we do

Our healthcare services

Supplier due diligence covering clinical safety evidence, patient data and cyber.

Criticality based on the clinical service at risk and how easily the supplier could be replaced.

AI supplier assessment before and after go-live.

Device lifecycle reviews, with end-of-support and reassessment triggers.

Contract, exit and data-portability standards.

A Proof of Value on one part of your supplier programme.